Construction of human naive antibody gene libraries

Methods in Molecular Biology

Volumn 907, Issue , 2012, Pages 85-107

  Hust, Michael ^a   Frenzel, André ^a   Meyer, Torsten ^a   Schirrmann, Thomas ^a   Dübel, Stefan ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

Antibody; Antibody gene library; Phage display; scFv

Indexed keywords

EID: 84867806182     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-974-7_5     Document Type: Review

References (69)

1. Smith GP (1985) Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228:1315-1317
2. Clackson T, Hoogenboom HR, Grif fi ths AD, Winter G (1991) Making antibody fragments using phage display libraries. Nature 352(624-8):1907718
3. McCafferty J, Grif fi ths AD, Winter G, Chiswell DJ (1990) Phage antibodies: fi lamentous phage displaying antibody variable domains. Nature 348:552-554
4. Barbas CF, Kang AS, Lerner RA, Benkovic SJ (1991) Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci U S A 88:7978-7982
5. Breitling F, Dübel S, Seehaus T, Klewinghaus I, Little M (1991) A surface expression vector for antibody screening. Gene 104:147-153
6. Hoogenboom HR, Grif fi ths AD, Johnson KS, Chiswell DJ, Hudson P, Winter G (1991) Multi-subunit proteins on the surface of fi lamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucl Acids Res 19:4133-4137
7. Parmley SF, Smith GP (1988) Antibodyselectable fi lamentous fd phage vectors: af fi nity puri fi cation of target genes. Gene 73:305-318
8. Hust M, Maiss E, Jacobsen H-J, Reinard T (2002) The production of a genus-speci fi c recombinant antibody (scFv) using a recombinant potyvirus protease. J Virol Methods 106:225-233
9. Kirsch M, Hülseweh B, Nacke C, Rülker T, Schirrmann T, Marschall H-J, Hust M, Dübel S (2008) Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV). BMC Biotechnol 8:66
10. Moghaddam A, Borgen T, Stacy J, Kausmally L, Simonsen B, Marvik OJ, Brekke OH, Braunagel M (2003) Identi fi cation of scFv antibody fragments that speci fi cally recognise the heroin metabolite 6-monoacetylmorphine but not morphine. J Immunol Methods 280:139-155
11. Schütte M, Thullier P, Pelat T, Wezler X, Rosenstock P, Hinz D, Kirsch MI, Hasenberg M, Frank R, Schirrmann T et al (2009) Identi fi cation of a putative Crf splice variant and generation of recombinant antibodies for the speci fi c detection of Aspergillus fumigatus. PLoS One 4:e6625
12. Hust M, Dübel S, Schirrmann T (2007) Selection of recombinant antibodies from antibody gene libraries. Methods Mol Biol 408:243-255
13. Schirrmann T, Hust M (2010) Construction of human antibody gene libraries and selection of antibodies by phage display. Methods Mol Biol 651:177-209
14. Alonso-Ruiz A, Pijoan JI, Ansuategui E, Urkaregi A, Calabozo M, Quintana A (2008) Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of ef fi cacy and safety. BMC Musculoskelet Disord 9:52
15. Schirrmann T, Meyer T, Schütte M, Frenzel A, Hust M (2011) Phage display for the generation of antibodies for proteome research, diagnostics and therapy. Molecules 16:412-426
16. Thie H, Meyer T, Schirrmann T, Hust M, Dübel S (2008) Phage display derived therapeutic antibodies. Curr Pharm Biotechnol 9:439-446
17. Vaughan TJ, Williams AJ, Pritchard K, Osbourn JK, Pope AR, Earnshaw JC, McCafferty J, Hodits RA, Wilton J, Johnson KS (1996) Human antibodies with sub-nanomolar af fi nities isolated from a large non-immunized phage display library. Nat Biotechnol 14:309-314
18. Wallace DJ, Stohl W, Furie RA, Lisse JR, McKay JD, Merrill JT, Petri MA, Ginzler EM, Chatham WW, McCune WJ et al (2009) A phase II, randomized, double-blind, placebocontrolled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus. Arthritis Rheum 61:1168-1178
19. Mazumdar S (2009) Raxibacumab. MAbs 1:531-538
20. Berglund L, Björling E, Oksvold P, Fagerberg L, Asplund A, Szigyarto CA-K, Persson A, Ottosson J, Wernérus H, Nilsson P et al (2008) A genecentric Human Protein Atlas for expression pro fi les based on antibodies. Mol Cell Proteomics 7:2019-2027
21. Dübel S, Stoevesandt O, Taussig MJ, Hust M (2010) Generating recombinant antibodies to the complete human proteome. Trends Biotechnol 28:333-339
22. Hust M, Dübel S (2004) Mating antibody phage display with proteomics. Trends Biotechnol 22:8-14
23. Taussig MJ, Stoevesandt O, Borrebaeck CAK, Bradbury AR, Cahill D, Cambillau C, de Daruvar A, Dübel S, Eichler J, Frank R et al (2007) ProteomeBinders: planning a European resource of af fi nity reagents for analysis of the human proteome. Nat Methods 4:13-17
24. Wingren C, James P, Borrebaeck CAK (2009) Strategy for surveying the proteome using af fi nity proteomics and mass spectrometry. Proteomics 9:1511-1517
25. Hust M, Meyer T, Voedisch B, Rülker T, Thie H, El-Ghezal A, Kirsch MI, Schütte M, Helmsing S, Meier D et al (2011) A human scFv antibody generation pipeline for proteome research. J Biotechnol 152:159-170
26. Mersmann M, Meier D, Mersmann J, Helmsing S, Nilsson P, Gräslund S, Structural Genomics Consortium, Colwill K, Hust M, Dübel S (2010) Towards proteome scale antibody selections using phage display. N Biotechnol 27:118-128
27. Pershad K, Pavlovic JD, Gräslund S, Nilsson P, Colwill K, Karatt-Vellatt A, Scho fi eld DJ, Dyson MR, Pawson T, Kay BK et al (2010) Generating a panel of highly speci fi c antibodies to 20 human SH2 domains by phage display. Protein Eng Des Sel 23:279-288
28. Buckler DR, Park A, Viswanathan M, Hoet RM, Ladner RC (2008) Screening isolates from antibody phage-display libraries. Drug Discov Today 13:318-324
29. Hallborn J, Carlsson R (2002) Automated screening procedure for high-throughput generation of antibody fragments. Biotechniques Suppl
30. Konthur Z, Hust M, Dübel S (2005) Perspectives for systematic in vitro antibody generation. Gene 364:19-29
31. Duggan JM, Coates DM, Ulaeto DO (2001) Isolation of single-chain antibody fragments against Venezuelan equine encephalomyelitis virus from two different immune sources. Viral Immunol 14:263-273
32. Meyer T, Stratmann-Selke J, Meens J, Schirrmann T, Gerlach GF, Frank R, Dübel S, Strutzberg-Minder K, Hust M (2011) Isolation of scFv fragments speci fi c to OmpD of Salmonella Typhimurium. Vet Microbiol 147:162-169
33. Pitaksajjakul P, Lekcharoensuk P, Upragarin N, Barbas CF, Ibrahim MS, Ikuta K, Ramasoota P (2010) Fab MAbs speci fi c to HA of in fl uenza virus with H5N1 neutralizing activity selected from immunized chicken phage library. Biochem Biophys Res Commun 395:496-501
34. Hunt AR, Frederickson S, Maruyama T, Roehrig JT, Blair CD (2010) The fi rst human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with signi fi cant virus neutralizing activity. PLoS Negl Trop Dis 4:e739
35. Kang X, Yang B-A, Hu Y, Zhao H, Xiong W, Yang Y, Si B, Zhu Q (2006) Human neutralizing Fab molecules against severe acute respiratory syndrome coronavirus generated by phage display. Clin Vaccine Immunol 13:953-957
36. Pelat T, Hust M, Hale M, Lefranc M-P, Dübel S, Thullier P (2009) Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity. BMC Biotechnol 9:60
37. Pelat T, Hust M, Laf fl y E, Condemine F, Bottex C, Vidal D, Lefranc M-P, Dübel S, Thullier P (2007) High-af fi nity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation. Antimicrob Agents Chemother 51:2758-2764
38. Sun L, Lu X, Li C, Wang M, Liu Q, Li Z, Hu X, Li J, Liu F, Li Q et al (2009) Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against in fl uenza A H5N1 viruses. PLoS One 4:e5476
39. Pelat T, Hust M, Thullier P (2009) Obtention and engineering of non-human primate (NHP) antibodies for therapeutics. Mini Rev Med Chem 9:1633-1638
40. Pelat T, Bedouelle H, Rees AR, Crennell SJ, Lefranc M-P, Thullier P (2008) Germline humanization of a non-human primate antibody that neutralizes the anthrax toxin, by in vitro and in silico engineering. J Mol Biol 384:1400-1407
41. Pelat T, Thullier P (2009) Non-human primate immune libraries combined with germline humanization: an (almost) new, and powerful approach for the isolation of therapeutic antibodies. MAbs 1:377-381
42. Bradbury ARM, Sidhu S, Dübel S, McCafferty J (2011) Beyond natural antibodies: the power of in vitro display technologies. Nat Biotechnol 29:245-254
43. Winter G, Grif fi ths AD, Hawkins RE, Hoogenboom HR (1994) Making antibodies by phage display technology. Annu Rev Immunol 12:433-455
44. de Haard HJ, van Neer N, Reurs A, Hufton SE, Roovers RC, Henderikx P, de Bruïne AP, Arends JW, Hoogenboom HR (1999) A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high af fi nity antibodies. J Biol Chem 274:18218-18230
45. Scho fi eld DJ, Pope AR, Clementel V, Buckell J, Chapple SD, Clarke KF, Conquer JS, Crofts AM, Crowther SRE, Dyson MR et al (2007) Application of phage display to high throughput antibody generation and characterization. Genome Biol 8:R254
46. Goletz S, Christensen PA, Kristensen P, Blohm D, Tomlinson I, Winter G, Karsten U (2002) Selection of large diversities of antiidiotypic antibody fragments by phage display. J Mol Biol 315:1087-1097
47. Grif fi ths AD, Williams SC, Hartley O, Tomlinson IM, Waterhouse P, Crosby WL, Kontermann RE, Jones PT, Low NM, Allison TJ (1994) Isolation of high af fi nity human antibodies directly from large synthetic repertoires. EMBO J 13:3245-3260
48. Pini A, Viti F, Santucci A, Carnemolla B, Zardi L, Neri P, Neri D (1998) Design and use of a phage display library. Human antibodies with subnanomolar af fi nity against a marker of angiogenesis eluted from a two-dimensional gel. J Biol Chem 273:21769-21776
49. Hoet RM, Cohen EH, Kent RB, Rookey K, Schoonbroodt S, Hogan S, Rem L, Frans N, Daukandt M, Pieters H et al (2005) Generation of high-af fi nity human antibodies by combining donor-derived and synthetic complementarity-determining- region diversity. Nat Biotechnol 23:344-348
50. Knappik A, Ge L, Honegger A, Pack P, Fischer M, Wellnhofer G, Hoess A, Wölle J, Plückthun A, Virnekäs B (2000) Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J Mol Biol 296:57-86
51. Rothe C, Urlinger S, Löhning C, Prassler J, Stark Y, Jäger U, Hubner B, Bardroff M, Pradel I, Boss M et al (2008) The human combinatorial antibody library HuCAL GOLD combines diversi fi cation of all six CDRs according to the natural immune system with a novel display method for ef fi cient selection of high-af fi nity antibodies. J Mol Biol 376:1182-1200
52. Hust M, Dübel S (2005) Phage display vectors for the in vitro generation of human antibody fragments. Methods Mol Biol 295:71-96
53. Johansen LK, Albrechtsen B, Andersen HW, Engberg J (1995) pFab60: a new, ef fi cient vector for expression of antibody Fab fragments displayed on phage. Protein Eng 8:1063-1067
54. Little M, Welschof M, Braunagel M, Hermes I, Christ C, Keller A, Rohrbach P, Kürschner T, Schmidt S, Kleist C et al (1999) Generation of a large complex antibody library from multiple donors. J Immunol Methods 231:3-9
55. Welschof M, Terness P, Kipriyanov SM, Stanescu D, Breitling F, Dörsam H, Dübel S, Little M, Opelz G (1997) The antigen-binding domain of a human IgG-anti-F(ab )2 autoantibody. Proc Natl Acad Sci U S A 94:1902-1907
56. McCafferty J, Fitzgerald KJ, Earnshaw J, Chiswell DJ, Link J, Smith R, Kenten J (1994) Selection and rapid puri fi cation of murine antibody fragments that bind a transition-state analog by phage display. Appl Biochem Biotechnol 47:157-171
57. Krebber A, Bornhauser S, Burmester J, Honegger A, Willuda J, Bosshard HR, Plückthun A (1997) Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system. J Immunol Methods 201:35-55
58. Akamatsu Y, Cole MS, Tso JY, Tsurushita N (1993) Construction of a human Ig combinatorial library from genomic V segments and synthetic CDR3 fragments. J Immunol 151:4651-4659
59. Hoogenboom HR, Winter G (1992) By-passing immunisation. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro. J Mol Biol 227:381-388
60. Nissim A, Hoogenboom HR, Tomlinson IM, Flynn G, Midgley C, Lane D, Winter G (1994) Antibody fragments from a "single pot" phage display library as immunochemical reagents. EMBO J 13:692-698
61. Desiderio A, Franconi R, Lopez M, Villani ME, Viti F, Chiaraluce R, Consalvi V, Neri D, Benvenuto E (2001) A semi-synthetic repertoire of intrinsically stable antibody fragments derived from a single-framework scaffold. J Mol Biol 310:603-615
62. Barbas CF, Bain JD, Hoekstra DM, Lerner RA (1992) Semisynthetic combinatorial antibody libraries: a chemical solution to the diversity problem. Proc Natl Acad Sci U S A 89: 4457-4461
63. Jirholt P, Ohlin M, Borrebaeck CA, Söderlind E (1998) Exploiting sequence space: shuf fl ing in vivo formed complementarity determining regions into a master framework. Gene 215:471-476
64. Söderlind E, Strandberg L, Jirholt P, Kobayashi N, Alexeiva V, Aberg AM, Nilsson A, Jansson B, Ohlin M, Wingren C et al (2000) Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries. Nat Biotechnol 18:852-856
65. Hust M, Toleikis L, Dübel S (2007) Antibody phage display. In: Dübel S (ed) Handbook of therapeutic antibodies. Wiley-VCH, Weinheim, pp 45-68
66. Løset GA, Løbersli I, Kavlie A, Stacy JE, Borgen T, Kausmally L, Hvattum E, Simonsen B, Hovda MB, Brekke OH (2005) Construction, evaluation and re fi nement of a large human antibody phage library based on the IgD and IgM variable gene repertoire. J Immunol Methods 299:47-62
67. Sheets MD, Amersdorfer P, Finnern R, Sargent P, Lindquist E, Schier R, Hemingsen G, Wong C, Gerhart JC, Marks JD et al (1998) Ef fi cient construction of a large nonimmune phage antibody library: the production of high-af fi nity human single-chain antibodies to protein antigens. Proc Natl Acad Sci U S A 95:6157-6162
68. Hust M, Jostock T, Menzel C, Voedisch B, Mohr A, Brenneis M, Kirsch MI, Meier D, Dübel S (2007) Single chain Fab (scFab) fragment. BMC Biotechnol 7:14
69. Hust M, Dübel S (2010) Human antibody gene libraries. In: Kontermann R, Dübel S (eds) Antibody engineering. Springer, Heidelberg, pp 65-84